All Insights

Life Sciences and Healthcare

EU court issues significant decision on pharma-device 'borderline' product case

European ruling clarifies the definition of pharmacological action for health products
Intellectual property

European Council adopts negotiating mandate on patents for gene-edited plants

EU moves closer to regulatory change for gene-edited plants but still a long way to go
Life Sciences and Healthcare

EU proposes tailored approach to streamline biosimilar development

New EMA reflection paper signals a step change in biosimilar approval, reducing requirements while maintaining standards
Life Sciences and Healthcare

New regulations signal next step for precision bred plants in England

Government sets out new simplified authorisation process for precision bred organisms
Regulatory and compliance

How is the UK regulatory landscape set to change?

The government is driving a pro-growth agenda, leading to transformative changes in regulatory operations
Life Sciences and Healthcare

EU set to upgrade medtech and diagnostics regulations

Commission-led targeted evaluation and reforms to the EU medical devices regulatory framework are reshaping the sector
Life Sciences and Healthcare

EU regulatory activity is driving comprehensive reforms for pharma in 2025

The European Union's regulatory framework for the pharmaceutical sector is undergoing significant transformations
Commercial

New EU packaging and waste regulation comes into force to promote sustainability

Effective implementation of this advance for the circular economy now depends on national legislation by Member States
Regulatory and compliance

Court of Appeal rules on duty to clarify tender submissions with bidders in UK public procurement

Decision explains when contracting authorities must clarify incomplete or ambiguous information in tender submissions
Life Sciences and Healthcare

The fight against counterfeit medicines in Italy

The Italian legislative decree implementing Regulation (EU) 2016/161 enters into force
Life Sciences and Healthcare

The Future of Cannabis in Germany: What to Expect After the 2025 Elections

The German cannabis industry is transforming rapidly. The introduction of the Cannabis Act (CanG) in April 2024 brought significant changes
Regulatory and compliance

New NPPS sets out 'value for money' message for UK public procurement

Government wants public bodies to use procurement to drive growth, social and economic value, and commercial capability